1 / 15

Chapter 18 Vaccines

Chapter 18 Vaccines. Termed coined by Pasteur to honor Jenner’s work Vaccines are cost-effective uses of our immune system Dramatic reduction of Diptheria Measles Mumps Pertussis Polio Tetanus No more naturally acquired cases of smallpox!. Still a significant need for new vaccines.

Lucy
Télécharger la présentation

Chapter 18 Vaccines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chapter 18 Vaccines • Termed coined by Pasteur to honor Jenner’s work • Vaccines are cost-effective uses of our immune system • Dramatic reduction of • Diptheria • Measles • Mumps • Pertussis • Polio • Tetanus • No more naturally acquired cases of smallpox!

  2. Still a significant need for new vaccines • For other diseases: TB malaria HIV • Increase safety of present vaccine, lower cost, and dissemination • Road to vaccine development is long and laden with: • Side effects • Exascerbation of disease state • Acquisition of disease state!

  3. Immunization:Passive Immunity & Short-term protection • Transient protection (remedy for current problem) • Involves transfer of preformed Ig: • between ☥ and fetus (trans-placental) & colostrum • Or by injection • Given to those exposed to botulism, tetanus, diptheria, hepatitis, rabies, measles, snake/insect bites • Provides immediate protection to healthcare/travellers • Passive immunity does not activate IS! and produces no memory

  4. Immunization:Risks of Passive Immunity If Antibody is produced in another spp, the human recipient can produce an IR vs it… In some  IgE production vs isotypic Ab -> systemic mast cell degran -> anaphylaxis In others  IgM or IgG vs isotype -> complement activation -> Type III Rxn If human gammaglobulin results can be less severe

  5. Immunization:Active Immunization and Long-term protection • Promotes protective immunity and imm memory • Is achieved by: • Natural infection • Artificial intro of whole cells/antigens • Immune system plays an ACTIVE role -> stim Ag-reactive T/B cells • Immunizations have played a sig role in decrease of infect. disease –esp in children • Yet, recent drop in immunization rates

  6. Childhood vaccines • 7 major vaccines: • HepB • DTaP • IPV • MMR • Hib • Var • PCV *children require booster shots for most… (American Academy of Pediatrics, 2002)

  7. Adult vaccines (dep on risk group) • For those living in close quarters/  immunity • Meningitis (Hib) • Pneumonia (PCV) • Influenza • For travelers to endemic areas: • Cholera Meningits • Typhus Yellow fever • Typhoid Polio • Hepatitis *Anthrax

  8. Designing vaccines Important questions to consider: 1- Which IS should be activated? 2- Is immunologic memory stimulated? This depends on the disease.. Influenza has a short incubation (1-2 d) effective imm vs flu depends on maintaining hi levels of Ig through repeat immunizations Polio virus has a longer incubation (>3d) gives memory cells time to produce serum Ig

  9. Whole Organism Vaccines • Attenuated viruses and bacteria -can still grow to a degree w/i inoc. host Positives: Provides prolonged IS exposure to epitopes > immunogenicity, > memory Typically req. ONLY 1 shot Stimulates host cell-mediated response Negatives Poss. of reversion to virulent form and side effects Ex: Polio and Measles

  10. Whole Organism Vaccines • Inactivated viruses and bacteria -can be performed with heat or chemicals* (formaldehyde, alkylating agents) • Usually requires repeated boosters • Predominantly humoral IR • **risks of containing active pathogen

  11. “Parts” – purified macromolecules as vaccines Avoids the risks of the ‘whole org’ vaccines -3 forms: inactivated exotoxin capsular polysaccharide recombinant MO antigens • Inact. exotoxin (“Toxoids”) -purify exotoxin, treat with formaldehyde -produces anti-toxin Ig which bind to toxin -exotoxin genes can be cloned/recombined in cells to produce large quantities **used for diptheria and tetanus

  12. “Parts” – purified macromolecules as vaccines 2) Capsular polysaccharides- -Anti-phagocytic mechanism -Vaccines using capsular components stim Ig prod -Vaccines for Strep pneu, N. meningitidis -> purified polysacch injected subcutaneously to activate memory B cells and IgA response! Can invoke Th activation if polysacch is added to protein carrier (Ex: Hib is cap polysacch linked to tetanus toxoid)

  13. “Parts” – purified macromolecules as vaccines 3) Recombinant MO Antigens – HepB surface Ag (HBsAg) – cloned in yeast -may be able to produce large amts of vaccine this way! -hope for 250 million+ carriers of chronic HepB worldwide

  14. Recombinant Vector Vaccines -Genes encoding significant Ag’s from pathogens may be transferred to attenuated viruses/bacteria Vectors include: vaccinia, polio, adenoviruses Salmonella, BCG strain of M. bovis, oral Strep Other vectors may prove to be safer

  15. DNA vaccines:

More Related